Ifrah Financial Services Inc. Sells 93 Shares of Zoetis Inc. (NYSE:ZTS)

Ifrah Financial Services Inc. cut its holdings in Zoetis Inc. (NYSE:ZTS) by 4.2% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,129 shares of the company’s stock after selling 93 shares during the period. Ifrah Financial Services Inc.’s holdings in Zoetis were worth $351,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in ZTS. Rakuten Securities Inc. raised its position in shares of Zoetis by 5,533.3% during the 4th quarter. Rakuten Securities Inc. now owns 169 shares of the company’s stock valued at $28,000 after purchasing an additional 166 shares during the period. Navigoe LLC bought a new stake in shares of Zoetis during the 4th quarter valued at $30,000. Murphy & Mullick Capital Management Corp bought a new stake in shares of Zoetis during the 4th quarter valued at $44,000. Sound Income Strategies LLC raised its position in shares of Zoetis by 141.4% during the 1st quarter. Sound Income Strategies LLC now owns 280 shares of the company’s stock valued at $46,000 after purchasing an additional 164 shares during the period. Finally, Bfsg LLC raised its position in shares of Zoetis by 614.6% during the 1st quarter. Bfsg LLC now owns 293 shares of the company’s stock valued at $48,000 after purchasing an additional 252 shares during the period. 92.80% of the stock is currently owned by institutional investors.

Insider Activity at Zoetis

In other Zoetis news, EVP Roxanne Lagano sold 652 shares of Zoetis stock in a transaction on Tuesday, June 3rd. The shares were sold at an average price of $170.00, for a total value of $110,840.00. Following the completion of the transaction, the executive vice president directly owned 15,129 shares of the company’s stock, valued at $2,571,930. This trade represents a 4.13% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. 0.16% of the stock is owned by insiders.

Analyst Ratings Changes

Several analysts have recently commented on the stock. Stifel Nicolaus downgraded shares of Zoetis from a “buy” rating to a “hold” rating and decreased their price objective for the company from $165.00 to $160.00 in a research report on Wednesday, June 18th. UBS Group decreased their price objective on shares of Zoetis from $189.00 to $170.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 7th. Finally, Piper Sandler raised their price objective on shares of Zoetis from $205.00 to $210.00 and gave the company an “overweight” rating in a research report on Monday, May 12th. Two investment analysts have rated the stock with a hold rating, seven have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $212.13.

Zoetis Stock Performance

ZTS opened at $159.19 on Monday. The stock has a market capitalization of $70.87 billion, a price-to-earnings ratio of 28.58, a PEG ratio of 2.64 and a beta of 0.91. The company has a fifty day moving average of $161.16 and a 200 day moving average of $162.08. Zoetis Inc. has a fifty-two week low of $139.70 and a fifty-two week high of $200.33. The company has a debt-to-equity ratio of 1.12, a quick ratio of 1.04 and a current ratio of 1.74.

Zoetis (NYSE:ZTS) last posted its earnings results on Tuesday, May 6th. The company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.08. The company had revenue of $2.22 billion during the quarter, compared to analysts’ expectations of $2.20 billion. Zoetis had a net margin of 27.12% and a return on equity of 55.48%. Zoetis’s quarterly revenue was up 1.4% on a year-over-year basis. During the same period last year, the company posted $1.38 earnings per share. As a group, sell-side analysts forecast that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 3rd. Shareholders of record on Friday, July 18th will be paid a $0.50 dividend. The ex-dividend date is Friday, July 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.26%. Zoetis’s payout ratio is currently 35.91%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.